Cancer News and Research

Latest Cancer News and Research

Scientists develop technique to predict new target diseases for existing drugs

Scientists at the University of North Carolina at Chapel Hill School of Medicine and the University of California, San Francisco have developed and experimentally tested a technique to predict new target diseases for existing drugs.

4 Nov 2009

Patients who have an undetectable level of PSA after therapy have good chance of being cured

Fox Chase Cancer Center researchers report that radiation therapy alone can reduce prostate specific antigen (PSA) levels below detectable amounts in prostate cancer patients. Patients who have an undetectable level of PSA after therapy have less chance of biochemical failure than other patients and a good chance of being cured.

4 Nov 2009

Phase Forward and PharmaNet Development Group sign multi-year agreement

Phase Forward, a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year agreement with PharmaNet Development Group, Inc., a global drug development services company, that enables PharmaNet to offer Phase Forward’s InForm™ electronic data capture (EDC) solution to PharmaNet customers worldwide.

4 Nov 2009

Stress-reduction workshops for women with history of breast cancer

Are you stressed? Do you have a family history of breast cancer? Health SMART is a study is being conducted by researchers at Fred Hutchinson Cancer Research Center to see how stress-reduction workshops can help women with a family history of breast cancer manage their everyday stresses and cancer-risk concerns.

4 Nov 2009

Canadian patients have less access to the latest medicines, says report

Canadian patients have less access to the latest medicines when compared to the world's developed countries, concludes a comprehensive new report released today. The Report shows Canada ranks 20th out of 25 OECD countries in public reimbursement of new drug therapies. Canada's grade of 56% is comparable with Iceland, Slovakia and Turkey.

4 Nov 2009

Predictive Biosciences commences clinical trials of its bladder cancer assay

Predictive Biosciences Inc. today announced the publication of pilot study results in the November issue of the Journal of Urology, highlighting the Company’s novel urinary biomarker approach to bladder cancer detection that achieves exceptionally high Negative and Positive Predictive Values (NPV and PPV).

4 Nov 2009

AUA clarifes recommendations on prostate cancer testing with PSA test and DRE

The American Urological Association (AUA) is aware of recent news reports disparaging prostate cancer testing. We are concerned that these reports are causing significant confusion for patients and we wish to clarify our recommendations on prostate cancer testing with the prostate-specific antigen (PSA) test and digital rectal exam (DRE). The AUA strongly supports early prostate cancer detection and feels it is in a man's best interest to consider being tested for prostate cancer.

4 Nov 2009

LIFE Biosystems to support UT Southwestern's Clinical Trials Management System deployment

LIFE Biosystems AG announced today that it has entered into a master agreement with The University of Texas Southwestern Medical Center at Dallas to provide clinical research consulting services in the area of Clinical Trials Management System (CTMS) deployment support. Financial terms of the agreement were not disclosed.

4 Nov 2009

Weightlifting increases self-esteem among breast cancer survivors: Study

In addition to building muscle, weightlifting is also a prescription for self-esteem among breast cancer survivors, according to new University of Pennsylvania School of Medicine research. Breast cancer survivors who lift weights regularly feel better about bodies and their appearance and are more satisfied with their intimate relationships compared with survivors who do not lift weights, according to a new study published in the journal Breast Cancer Research and Treatment.

4 Nov 2009

Medical imaging cuts will cost lives

Medical imaging cuts contained in the 2010 Medicare Physician Fee Schedule will restrict life-saving imaging care to large hospitals, produce longer commutes and wait times to receive care, and cause life threatening delays in diagnosis and treatment of cancer and other serious illnesses.

4 Nov 2009

Obese lung cancer patients with diabeties more likely to develop chest wall pain after receiving stereotactic body radiation therapy

Obesity, not the amount of radiation given, is the greatest factor in whether early-stage lung cancer patients develop chest wall pain after receiving stereotactic body radiation therapy to the chest wall, with obese patients being more than twice as likely to develop chronic pain compared to those who have less body weight, according to a first-of-its-kind study presented Tuesday, November 3, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

4 Nov 2009

MagForce Nanotechnologies completes clinical trial of Nano-Cancer therapy in glioblastoma patients

MagForce Nanotechnologies AG has successfully completed its single-arm clinical trial on the efficacy of thermotherapy using superparamagnetic nanoparticles in patients with recurrent glioblastoma.

4 Nov 2009

AJCC Cancer Staging Manual brings together the relevant, evidence-based criteria for staging of cancer

Physicians and health care professionals around the world need a tool to facilitate the uniform description and reporting of cancer. Proper staging is essential to determine appropriate treatment, evaluate results of management and clinical trials, and to serve as the standard for local, regional and international reporting on cancer incidence and outcomes.

4 Nov 2009

New improved enzyme could help facilitate spinal cord injuries

Researchers have developed an improved version of an enzyme that degrades the dense scar tissue that forms when the central nervous system is damaged. By digesting the tissue that blocks re-growth of damaged nerves, the improved enzyme - and new system for delivering it - could facilitate recovery from serious central nervous system injuries.

4 Nov 2009

Tinnitus patients need more support and advice on healthcare options

As many as one in seven people will experience tinnitus, or ringing in their ears, at some time of their life, but not enough is being done to support patients who experience this distressing condition, according to an extensive research review in the November issue of the Journal of Clinical Nursing.

4 Nov 2009

superDimension's electromagnetic navigational bronchoscopy device receives AMA Category I CPT code

superDimension, Inc.®, a private company that develops minimally invasive interventional pulmonology devices, announced today that The American Medical Association (AMA) has issued a new Category I CPT® code for the use of the Company's electromagnetic navigational bronchoscopy (ENB) device to navigate to lesions or spots deep in the lungs.

4 Nov 2009

Webinar series on neuroendocrine tumours

The Canadian Oncology Societies and the Canadian Association of Medical Oncologists continue the series of webcasts on Neuroendocrine Tumours by presenting an hour-long webinar by Dr. Walter Kocha, Dr. Amil Shah, and Dr. Peter Metrakos. This webinar is part two of a three-part series and will cover the subjects of Surgery, Cardiology, Radiology & Principals of Medical Management in Treatment.

4 Nov 2009

HER2-positive breast cancer patients can be treated with Trastuzumab and adjuvant radiation therapy

Standard adjuvant treatment for HER2-positive breast cancer patients, following primary surgery for their cancer, is Trastuzumab (Herceptin)--typically used in combination with chemotherapy.

4 Nov 2009

Experts team up to measure the hearing of people with AIDS

Specialists in HIV and in hearing at the University of Rochester Medical Center are teaming up to measure the hearing of people with AIDS.

4 Nov 2009

Some patients with tonsil cancer can be treated with radiation, says PMH study

Clinical researchers at Princess Margaret Hospital (PMH) have confirmed that patients with oropharyngeal squamous cell cancer ("tonsil cancer") harbour a common type of human papilloma virus (HPV16), but also that such cancers are very sensitive to radiation. For some patients, this may mean successful treatment with radiation alone and avoiding the side effects of chemotherapy.

4 Nov 2009

Cancer News and Research

Latest Cancer News and Research

Scientists develop technique to predict new target diseases for existing drugs

Patients who have an undetectable level of PSA after therapy have good chance of being cured

Phase Forward and PharmaNet Development Group sign multi-year agreement

Stress-reduction workshops for women with history of breast cancer

Canadian patients have less access to the latest medicines, says report

Predictive Biosciences commences clinical trials of its bladder cancer assay

AUA clarifes recommendations on prostate cancer testing with PSA test and DRE

LIFE Biosystems to support UT Southwestern's Clinical Trials Management System deployment

Weightlifting increases self-esteem among breast cancer survivors: Study

Medical imaging cuts will cost lives

Obese lung cancer patients with diabeties more likely to develop chest wall pain after receiving stereotactic body radiation therapy

MagForce Nanotechnologies completes clinical trial of Nano-Cancer therapy in glioblastoma patients

AJCC Cancer Staging Manual brings together the relevant, evidence-based criteria for staging of cancer

New improved enzyme could help facilitate spinal cord injuries

Tinnitus patients need more support and advice on healthcare options

superDimension's electromagnetic navigational bronchoscopy device receives AMA Category I CPT code

Webinar series on neuroendocrine tumours

HER2-positive breast cancer patients can be treated with Trastuzumab and adjuvant radiation therapy

Experts team up to measure the hearing of people with AIDS

Some patients with tonsil cancer can be treated with radiation, says PMH study

Understanding the DNA Damage Response in Innate Immunity eBook

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in